JPS5961777A - Analytical system of bile acid - Google Patents
Analytical system of bile acidInfo
- Publication number
- JPS5961777A JPS5961777A JP17263182A JP17263182A JPS5961777A JP S5961777 A JPS5961777 A JP S5961777A JP 17263182 A JP17263182 A JP 17263182A JP 17263182 A JP17263182 A JP 17263182A JP S5961777 A JPS5961777 A JP S5961777A
- Authority
- JP
- Japan
- Prior art keywords
- bile acids
- total
- column
- fractionated
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
この発明は胆汁酸の分析システムに関する。詳しくは各
種胆汁酸が共存する試料、例えば血清のごとき体液など
の総遊離型胆汁酸、総グリシン抱台型胆汁酸および総タ
ウリン抱台型胆汁酸を簡便に高感度で短時間にて分析し
うる分析システムに関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a bile acid analysis system. In detail, samples in which various bile acids coexist, for example, total free bile acids, total glycine-bound bile acids, and total taurine-bound bile acids, such as body fluids such as serum, can be easily analyzed with high sensitivity and in a short time. Regarding the water analysis system.
従来、胆汁酸の分析としては総胆汁酸の分析〃(行われ
ているが、これでは情報が少ないので総遊離型胆汁酸、
総グリシン抱台型胆汁酸および総タウリン抱合型胆汁酸
の分析が望まれている。Conventionally, analysis of total bile acids has been carried out, but since there is little information on this, total free bile acids, total free bile acids,
Analysis of total glycine-conjugated bile acids and total taurine-conjugated bile acids is desired.
第1図に従来用いられている総110汁酸分析装置の概
略系統図を示しだ。試料は試料注入ポンプ(1)によっ
て注入され、次いで分析系路(2)とレファレンス系路
(3)とに2分されて供給される。反応試薬は反応試薬
注入ポンプ(4)と(5)とで分析系路(2)とレファ
レンス系路とにそれぞれ送られる。また緩衝液が緩ω(
」液送液ポンプ(8)と(9)とで分析系路(2)とし
77レンス糸路(3)とに送られる。(6)と(7)は
試料区分間の空気泡の注入用ポンプである。このように
して注入された試料、反応試薬および緩鈎液の混合物は
加熱炉四において60〜70°Cに加熱される。Figure 1 shows a schematic system diagram of a conventionally used total 110 acid analyzer. A sample is injected by a sample injection pump (1), and then divided into two parts: an analysis line (2) and a reference line (3). The reaction reagent is sent to the analysis system path (2) and the reference system path by reaction reagent injection pumps (4) and (5), respectively. Also, the buffer solution is loose ω(
The liquid is sent to the analytical system path (2) and the 77 lens thread path (3) by the liquid sending pumps (8) and (9). (6) and (7) are pumps for injecting air bubbles between sample sections. The thus injected mixture of sample, reaction reagent, and slow hook solution is heated to 60 to 70°C in heating furnace 4.
そして分析系路(2)に送られた液は固定化酵素カラム
(11)と反応コイ/I/(6)とを通過後螢光光度計
0灼にて螢光光度が測定される。・一方レファレンス系
路(3)に送られた液は反応コイル0]をjlii過後
螢先後螢光光度計1で螢光光度が測定される。次いで2
つの螢光光度データから総胆汁酸量が算出される。0萄
と09とは気泡放出孔である。After passing through the immobilized enzyme column (11) and the reaction carp/I/(6), the liquid sent to the analysis line (2) is measured for fluorescence intensity using a fluorophotometer. - On the other hand, the liquid sent to the reference system path (3) passes through the reaction coil 0 and then its fluorescence intensity is measured with a fluorophotometer 1. then 2
Total bile acid content is calculated from the two fluorescence data. 0 and 09 are bubble release holes.
上記の従来法では、試料の体液中に存在して固定化酵素
と反応する物質の影響を除くために加熱燻としてL/フ
ァレレン系路が設置され大型化している。−また試料区
分用の気泡を注入せねばならず気泡抜きによる試才1の
ロスが起こり分析感度が低下するという問題点を有する
。In the above-mentioned conventional method, an L/phalerene system is installed for heating and smoking in order to eliminate the influence of substances present in the body fluid of the sample and reacting with the immobilized enzyme, resulting in an increase in size. Another problem is that air bubbles for sample separation must be injected, resulting in a loss of sample size due to air bubble removal, resulting in a decrease in analytical sensitivity.
この弁明は上記間四点を解消するとともに、さらに総遊
削πり胆汁酸、総グリシン抱合型胆汁酸、総タウリン抱
合型胆汁酸の三つの胆汁酸群を分析しうる分析システム
であって、A)ピペリジノヒドロキシプロピルゲルのよ
うなイオン交換基を有する疎水性ゲル充填の服汁酸分画
部と、B)1以上の反応試薬液の送液部、3α−■SD
固定化酵素カラム、反応部および螢光光度測定部をこの
順で流路を介して連結してなり、□さらに前記送液部と
前記酵素カラムとの間に分画された胆汁酸の注入部を介
設し、総遊闘し!Ii!用4汁酸、総グリシン抱台型胆
汁酸および総タウリン抱合4り胆V1酸を分析[7うる
よう:’l’ff成してなる胆汁酸分析システムを提供
するものである、
′この発明の分析システムによれば3群の胆汁酸が分析
できるだけでなく次のような利点を有する。This defense solves the above four points, and is an analysis system that can further analyze three bile acid groups: total free π-conjugated bile acids, total glycine-conjugated bile acids, and total taurine-conjugated bile acids, A) A sucrose fractionation section filled with a hydrophobic gel having an ion exchange group such as piperidinohydroxypropyl gel, and B) A liquid delivery section for one or more reaction reagent solutions, 3α-■SD
An immobilized enzyme column, a reaction section, and a fluorescence measurement section are connected in this order via a flow path, and an injection section for fractionated bile acid is further provided between the liquid feeding section and the enzyme column. Interpose and have a total battle! Ii! The present invention provides a bile acid analysis system comprising: triglyceride bile acids, total glycine-conjugated bile acids, and total taurine-conjugated bile V1 acids. The analysis system not only allows analysis of three groups of bile acids, but also has the following advantages.
イオン交換基を有する疎水性ゲルカラムで試料を予め処
理することによって酵素と反応して分析に何重しくない
影唇を与える物質が除去されるので、前記従来法のよう
な加熱炉が不要になり全体の反応時間が短かくなる。こ
のため単位時間当りの分析処、1′!l!数が大となる
。また試料区分用の気泡の注入も不要となり気泡排出時
の試料のロスがなくなり感度が上昇する。まだレファレ
ンス部が不要になり分析装置dが簡略化される。By pre-treating the sample with a hydrophobic gel column containing ion exchange groups, substances that react with enzymes and cause undesirable effects on analysis are removed, eliminating the need for a heating furnace as in the conventional method. The overall reaction time is shortened. Therefore, the analysis time per unit time is 1'! l! The number becomes large. In addition, there is no need to inject air bubbles for sample separation, and there is no sample loss when air bubbles are discharged, increasing sensitivity. There is no need for a reference section, and the analyzer d is simplified.
この発明に係る分析システノ、は生体試料のように胆l
」イゾを多成分含有する試ネ・1の分析に好適である。The analytical system according to this invention is a biliary tract such as a biological sample.
” Suitable for analysis of test sample 1 containing multiple components of iso.
この発明の分析システムでは、試料によって、例えば血
油などの場合、常法によって脱塩、除蛋白処理が行われ
る。例えに、アンバーライトXAD−2(ローノ・アン
ドハース社製)や5ep−pakO+s (ウォーター
ズ社11jll )カラムを通過させて胆汁酸を保J、
lrさせておいて蒸留水で61′、浄した後エタノール
で溶出する。相られだ溶出液をイオン交換基を有する疎
水性ゲルによる処理に付して遊離型、グリシン抱合型及
びタウリン抱合型のII[1汁酸を含有スる3つのフラ
クション(それぞれFフラクション、Gフラクション及
びTフラクションと称する)に分画する。この分画方法
としては、市原らによって開発されだPiperidi
no−hydroxypropyl 8ephade
x 、LIl−26(PLiP Lll−20)(S
ephadex LIl−20ヲ化学修飾したもの。〕
を用いたカラムクロマトグラフィーがあげられる。In the analysis system of the present invention, depending on the sample, for example, in the case of blood oil, desalination and protein removal treatments are performed using conventional methods. For example, when bile acids are preserved by passing them through an Amberlite
The solution was allowed to cool for 61 minutes, washed with distilled water, and then eluted with ethanol. The combined eluate was treated with a hydrophobic gel containing ion-exchange groups to obtain three fractions containing free, glycine-conjugated, and taurine-conjugated II acids (F and G fractions, respectively). and T fraction). This fractionation method was developed by Ichihara et al.
no-hydroxypropyl 8ephade
x, LIl-26 (PLiP Lll-20) (S
A chemically modified version of ephadex LII-20. ]
Column chromatography using
このようにして慴られた各フラクションは次のような酵
素反応を利用して分析される。Each fraction thus obtained is analyzed using the following enzymatic reaction.
NAD N ADII
レゾルフィン レザズリン試*I中ノI]
d汁mll’i酵素8 a −1,I S D (3α
−hydroxysteroiddehydrogen
ase )によって酸化され共存させたNALIは同時
にN A I)Hにρ元される。ジアフォラーゼの共存
下N A D IIはN A IJに酸化され、共存さ
せたレッズリンは同時に螢光を発するレゾルフィンを生
成する。コノ螢光’hJ’Rの螢光光度を」11定して
胆汁酸が分析される。NAD N ADII Resorufin Resazurin Trial *I Middle I]
d juice mll'i enzyme 8 a -1, I S D (3α
-hydroxysteroiddehydrogen
NALI, which is oxidized and allowed to coexist with NALI), is simultaneously converted to NAI)H. In the presence of diaphorase, N A D II is oxidized to N A IJ, and the coexisting rezurin simultaneously produces resorufin, which emits fluorescence. Bile acids are analyzed by determining the fluorescence intensity of the fluorophore 'hJ'R.
第2図にこの発明の分析システムの一実施例の概略系統
図(′@l水併ゲルカラムは図示せず)を示した。すな
わちNAI)、レサズリンおよびジアファラーゼ含有の
緩衝溶液Qυをポンプ(ハ)で送りながら試料注入部(
ハ)から、予め疎水性ゲルカラムで分画された遊離型、
グリシン抱合1)すおよびタウリン抱合型の各胆汁酸の
フラクションの試料を注入する。固定化酵素カラム(3
α−ILsD)(ホ)と反応コイル(ハ)をJll】過
させて前記反応を完了させ螢光光度計(1)にて螢光光
度を4111定することによって各フラクションの総胆
汁酸が分析される。FIG. 2 shows a schematic system diagram of an embodiment of the analysis system of the present invention ('@l water-gel column is not shown). In other words, the sample injection part (NAI), resazurin, and diafarase-containing buffer solution Qυ is sent with the pump (c).
c), a free form pre-fractionated with a hydrophobic gel column,
Inject samples of the glycine- and taurine-conjugated fractions of each bile acid. Immobilized enzyme column (3
α-ILsD) (e) and the reaction coil (c) were allowed to pass through the reaction coil (c) to complete the reaction, and the total bile acids in each fraction were analyzed by measuring the fluorescence intensity at 4111 with a fluorophotometer (1). be done.
また第8図にはこの発明の胆汁酸分析装置の一変形例の
411’J略系続図(IT!水性ゲルカラムは図示せず
)を示した。すなわち、レサズリン、ジアフオフーゼ及
び1孝素(3α−T18 D )含有の緩衝溶液Ct1
)をポンプC’12で送るとともにN A T)含有の
M衝溶液c(東をポンプQ41で送りながら、試料注入
部弼から前記実施例と同様の各フラクションの試料を注
入する。次いで反応コイル(7)を通過させて前記反応
を完了させ螢光光ル計c3I)にて螢光光度を測定する
ことによって各フラクションの総胆汁酸が分析さtしる
。Furthermore, FIG. 8 shows a 411'J schematic diagram (IT! aqueous gel column not shown) of a modified example of the bile acid analyzer of the present invention. That is, a buffer solution Ct1 containing resazurin, diafuofuse, and 1-filament (3α-T18D)
) is fed with pump C'12, and while feeding M buffer solution c (east) containing NAT) with pump Q41, samples of each fraction are injected from the sample injection section 2 as in the previous example. Then, the reaction coil is (7) to complete the reaction, and the total bile acids in each fraction are analyzed by measuring the fluorescence intensity in a fluorometer (c3I).
第1図は従来用1いられている胆汁酸分析装置の概1烙
系統図、第2図はこの発明の胆汁酸の分析システムの一
実施5例の概略系統図、第3図はこの発明の胆汁酸分析
システムの一変形例の(I!Y略糸続図である。
(11、(4) 、 (5) 、 (8) 、(9)−
(ホ)、eつ・・・送液ポンプ、(6) 、 (7)・
・・空気泡注入ポンプ、(2)・・・分析系路、
(3)・・・レファレンス系路、OQ・・・加熱炉、
01)、 (:?A・・・固定化酵素カラム、
0り、(ハ)、0)・・・反応コイル、シυ・°・NA
Iノ、レサズリンーレよびジアフォヮーゼ含有のN衝溶
液、
6D・・°レサズリン、ジアフォラーゼおよび8α−E
[S I)酵米含有の緩衝溶液、
第1図
第2図Fig. 1 is a general system diagram of a conventional bile acid analyzer, Fig. 2 is a schematic system diagram of five embodiments of the bile acid analysis system of the present invention, and Fig. 3 is a schematic system diagram of the present invention. (11, (4), (5), (8), (9)-
(e), e...liquid pump, (6), (7).
... Air bubble injection pump, (2) ... Analysis system line,
(3)...Reference system line, OQ...Heating furnace,
01), (:?A...immobilized enzyme column,
0ri, (c), 0)...reaction coil, υ・°・NA
I, N buffer solution containing resazurin and diaphorase, 6D...°resazurin, diaphorase and 8α-E
[SI) Buffer solution containing fermented rice, Fig. 1 Fig. 2
Claims (1)
なイオン交換基を有する疎水性ゲル充填の胆汁酸分画部
と、B)1以上の反応試薬液の送液部、8α−1181
)固定化酵素カラム、反応部および螢光光度71ill
定部をこの順で流路を介して連結してなり、さらに前記
送液部と前記酵素カラムとの間に分画された胆汁酸の注
入部を介設し、総遊離型胆汁酸、総グリシン抱金型胆汁
酸および総タウリン抱台型胆汁酸を分析しうるよう構成
してなる胆汁酸分析システム。1. A) A bile acid fractionation section filled with a hydrophobic gel having an ion exchange group such as piperidinohydroxypropyl gel, and B) A liquid delivery section for one or more reaction reagent solutions, 8α-1181
) Immobilized enzyme column, reaction part and fluorescence intensity 71ill
The fixed parts are connected in this order via a flow path, and an injection part for fractionated bile acids is interposed between the liquid feeding part and the enzyme column, and total free bile acids and total free bile acids are separated. A bile acid analysis system configured to analyze glycine-conjugated bile acids and total taurine-conjugated bile acids.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP17263182A JPS5961777A (en) | 1982-09-30 | 1982-09-30 | Analytical system of bile acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP17263182A JPS5961777A (en) | 1982-09-30 | 1982-09-30 | Analytical system of bile acid |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS5961777A true JPS5961777A (en) | 1984-04-09 |
Family
ID=15945450
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP17263182A Pending JPS5961777A (en) | 1982-09-30 | 1982-09-30 | Analytical system of bile acid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5961777A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62209358A (en) * | 1986-03-11 | 1987-09-14 | Toyo Soda Mfg Co Ltd | System for automatic clinical analysis |
US4961345A (en) * | 1986-12-08 | 1990-10-09 | Fuji Electric Co., Ltd. | Vibration type transducer |
JPH048256U (en) * | 1990-05-01 | 1992-01-24 | ||
EP0821069A1 (en) * | 1996-07-23 | 1998-01-28 | Unitika Ltd. | Test strip using fluorescent chromogen |
DE112017003532T5 (en) | 2016-07-12 | 2019-04-04 | Panasonic Intellectual Property Management Co., Ltd. | Magnetic sensor and detection device using it |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5639797A (en) * | 1979-09-07 | 1981-04-15 | Japan Spectroscopic Co | Analytical method of bile acid and apparatus for the same |
-
1982
- 1982-09-30 JP JP17263182A patent/JPS5961777A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5639797A (en) * | 1979-09-07 | 1981-04-15 | Japan Spectroscopic Co | Analytical method of bile acid and apparatus for the same |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62209358A (en) * | 1986-03-11 | 1987-09-14 | Toyo Soda Mfg Co Ltd | System for automatic clinical analysis |
US4961345A (en) * | 1986-12-08 | 1990-10-09 | Fuji Electric Co., Ltd. | Vibration type transducer |
JPH048256U (en) * | 1990-05-01 | 1992-01-24 | ||
EP0821069A1 (en) * | 1996-07-23 | 1998-01-28 | Unitika Ltd. | Test strip using fluorescent chromogen |
US5912139A (en) * | 1996-07-23 | 1999-06-15 | Unitika, Ltd. | Test strip |
DE112017003532T5 (en) | 2016-07-12 | 2019-04-04 | Panasonic Intellectual Property Management Co., Ltd. | Magnetic sensor and detection device using it |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Waalkes | The determination of serotonin (5-hydroxytryptamine) in human blood | |
Carlson | Determination of free nicotinic acid in blood plasma | |
EP0097341B1 (en) | Sensitive tests for malignancies based on dna detection | |
US20180364249A1 (en) | Method of quantitative determination of sarcosine in a biological sample | |
Iadarola et al. | Recent applications of CE‐and HPLC‐MS in the analysis of human fluids | |
JPS5961777A (en) | Analytical system of bile acid | |
Zhang et al. | Rapid determination of free prolyl dipeptides and 4-hydroxyproline in urine using flow-gated capillary electrophoresis | |
Israels et al. | A microhemagglutination-inhibition assay for the quantitation of fibrinogen breakdown products | |
CN114624197A (en) | Method for detecting blood concentration of small molecule drug | |
CN102967713A (en) | Homocysteine detection kit and preparation method thereof | |
Miquel et al. | Quantification of mucin in human gallbladder bile: a fast, specific, and reproducible method | |
CA2148971A1 (en) | Calibrator matrix | |
CN114593979A (en) | Method for detecting low-abundance protein in body fluid sample based on mass spectrum | |
US20090311719A1 (en) | In vitro method for diagnosing neurodegenerative diseases | |
JPH02193071A (en) | Kit of reagent for measuring haptoglobin-hemoglobin complex and measuring method of haptoglobin-hemoglobin complex using the same | |
Govorun et al. | Proteomics and peptidomics in fundamental and applied medical studies | |
JPS5951349A (en) | Quantitative analysis of bile acid | |
CN118243826B (en) | Metabolite combination for assessing risk of biliary tract locking of neonate and application thereof | |
Sun et al. | Clinical applicability of acid phosphatase isoenzyme assay. | |
JPS5938651A (en) | Quantitative analysis of catecholamine | |
JPS59143957A (en) | Analysis of human hemoglobin | |
Wen et al. | Capillary electrophoresis of human follicular fluid | |
JPS61245059A (en) | Method of determining total quantity of digoxin | |
JPH08105875A (en) | Filler for separating lipoprotein, antibody column wherein the filler is filled, and method for analyzing remnant lipoprotein using the column | |
Bladek et al. | Application of Thin‐Layer Chromatography in Clinical Chemistry |